Advertisement

Topics

ALK-Abelló: ALK to accelerate launches of ODACTRA™ in the USA / ACARIZAX® in Canada

13:04 EDT 21 Aug 2017 | FinanzNachrichten

Copenhagen, 2017-08-21 18:59 CEST (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): -- The FDA has today transferred the US product licences for the SLIT-tablet portfolio to ALK allow...

Original Article: ALK-Abelló: ALK to accelerate launches of ODACTRA™ in the USA / ACARIZAX® in Canada

NEXT ARTICLE

More From BioPortfolio on "ALK-Abelló: ALK to accelerate launches of ODACTRA™ in the USA / ACARIZAX® in Canada"

Advertisement
Quick Search
Advertisement
Advertisement